ID: ALA3357615

Max Phase: Preclinical

Molecular Formula: C25H24BrN7O5

Molecular Weight: 582.42

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(N[C@@H]1C[C@@H](C(=O)NC[C@@H]2CC(Br)=NO2)N(C(=O)OCc2cnc3ccccc3c2)C1)c1cnccn1

Standard InChI:  InChI=1S/C25H24BrN7O5/c26-22-9-18(38-32-22)11-30-24(35)21-8-17(31-23(34)20-12-27-5-6-28-20)13-33(21)25(36)37-14-15-7-16-3-1-2-4-19(16)29-10-15/h1-7,10,12,17-18,21H,8-9,11,13-14H2,(H,30,35)(H,31,34)/t17-,18+,21+/m1/s1

Standard InChI Key:  RAVIIYNYIRHMNT-LQWHRVPQSA-N

Associated Targets(Human)

Protein-glutamine gamma-glutamyltransferase K 164 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Protein-glutamine gamma-glutamyltransferase 1221 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 582.42Molecular Weight (Monoisotopic): 581.1022AlogP: 2.15#Rotatable Bonds: 7
Polar Surface Area: 148.00Molecular Species: NEUTRALHBA: 9HBD: 2
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.55CX Basic pKa: 4.07CX LogP: 0.47CX LogD: 0.47
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.43Np Likeness Score: -1.27

References

1. Klöck C, Herrera Z, Albertelli M, Khosla C..  (2014)  Discovery of potent and specific dihydroisoxazole inhibitors of human transglutaminase 2.,  57  (21): [PMID:25333388] [10.1021/jm501145a]

Source